Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Hayat Pharmaceutical Industries Co (AMM:HPIC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Hayat Pharmaceutical Industries Co's EV-to-EBIT for today is
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil.
Hayat Pharmaceutical Industries Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD2.61 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Hayat Pharmaceutical Industries Co's EV-to-EBITDA for today is:
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil.
Hayat Pharmaceutical Industries Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD3.25 Mil.
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil.
Hayat Pharmaceutical Industries Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD16.32 Mil.
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil.
Hayat Pharmaceutical Industries Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD5.14 Mil.
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil.
Hayat Pharmaceutical Industries Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD4.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Enterprise Value Related Terms
Hayat Pharmaceutical Industries Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Enterprise Value Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Enterprise Value falls into.
Hayat Pharmaceutical Industries Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of JOD23.75 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Enterprise Value of JOD23.75 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's Enterprise Value too high?
Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Enterprise Value compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Enterprise Value of JOD23.75 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current Enterprise Value is JOD23.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current Enterprise Value is JOD23.75 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Enterprise Value is JOD23.75 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued.
The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74.
GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.
Key valuation signals for AMM:HPIC:
Enterprise Value: JOD23.75 Mil
GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
77GF Score
Get the complete analysis for AMM:HPIC
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
